Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease
J. Clin. Invest. Lemin Zheng, et al. 114:529 doi:10.1172/JCI21109 [Go to this article.]

Table 4
ApoA-I is a preferred target for nitration and chlorination within human aortic atherosclerotic lesions